Naltrexone And Bupropion
A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program
Orexigen Therapeutics, Inc · Phase 3 · Completed · Enrollment 793
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| NB32 | 66.39% | 41.49% | n/r | n/r |
| Placebo | 42.49% | 20.21% | n/r | n/r |
Not shown
Every selected arm is drawn.